These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 2566677)

  • 1. Effect of continuous exposure to selective D1 and D2 dopaminergic agonists on rotational behavior in supersensitive mice.
    Winkler JD; Weiss B
    J Pharmacol Exp Ther; 1989 May; 249(2):507-16. PubMed ID: 2566677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of stereotyped behavior and production of latent locomotor behaviors in mice treated continuously with quinpirole.
    Zhou LW; Qin ZH; Weiss B
    Neuropsychopharmacology; 1991 Jan; 4(1):47-55. PubMed ID: 1672250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of release of acetylcholine in the striatum in mice following continuous exposure to selective D1 and D2 dopaminergic agonists.
    Wang HY; Zhou LW; Friedman E; Weiss B
    Neuropharmacology; 1993 Jan; 32(1):85-91. PubMed ID: 8094235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nigral D1 and striatal D2 receptors mediate the behavioral effects of dopamine agonists.
    LaHoste GJ; Marshall JF
    Behav Brain Res; 1990 May; 38(3):233-42. PubMed ID: 1973041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective down-regulation of D1 dopamine mediated rotational behavior in supersensitive mice.
    Winkler JD; Callison K; Cass SA; Weiss B
    Neuropharmacology; 1988 Apr; 27(4):439-42. PubMed ID: 3138558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of chronic treatment with selective agonists on the subtypes of dopamine receptors.
    Subramaniam S; Lucki I; McGonigle P
    Brain Res; 1992 Feb; 571(2):313-22. PubMed ID: 1351781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. D1-like and D2-like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
    Paul ML; Graybiel AM; David JC; Robertson HA
    J Neurosci; 1992 Oct; 12(10):3729-42. PubMed ID: 1357113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
    Hu XT; Brooderson RJ; White FJ
    Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligodeoxynucleotide antisense to the D1 dopamine receptor mRNA inhibits D1 dopamine receptor-mediated behaviors in normal mice and in mice lesioned with 6-hydroxydopamine.
    Zhang SP; Zhou LW; Weiss B
    J Pharmacol Exp Ther; 1994 Dec; 271(3):1462-70. PubMed ID: 7996459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective protection from the inhibition by EEDQ of D1 and D2 dopamine agonist-induced rotational behavior in mice.
    Goodale DB; Jacobi AG; Seyfried DM; Weiss B
    Pharmacol Biochem Behav; 1988 Jun; 30(2):457-62. PubMed ID: 2902647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S; Bergman J
    J Pharmacol Exp Ther; 1993 Nov; 267(2):765-75. PubMed ID: 7902432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The D2 agonist quinpirole potentiates the discriminative stimulus effects of the D1 agonist SKF 38393.
    Williams JE; Woolverton WL
    Pharmacol Biochem Behav; 1990 Oct; 37(2):289-93. PubMed ID: 1981936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective D1 and D2 dopamine agonists produce opposing effects in place conditioning but not in conditioned taste aversion learning.
    Hoffman DC; Beninger RJ
    Pharmacol Biochem Behav; 1988 Sep; 31(1):1-8. PubMed ID: 2908061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D1 and D2 dopamine receptor mechanisms in dopaminergic behaviors.
    Koller WC; Herbster G
    Clin Neuropharmacol; 1988 Jun; 11(3):221-31. PubMed ID: 3261198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effects of D1 and D2 dopamine agonists on turning behaviour in rats.
    Robertson GS; Robertson HA
    Brain Res; 1986 Oct; 384(2):387-90. PubMed ID: 2946360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions of D1 and D2 dopamine receptors on the ipsilateral vs. contralateral side in rats with unilateral lesions of the dopaminergic nigrostriatal pathway.
    Sonsalla PK; Manzino L; Heikkila RE
    J Pharmacol Exp Ther; 1988 Oct; 247(1):180-5. PubMed ID: 2971797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.